首页 | 本学科首页   官方微博 | 高级检索  
检索        

视网膜母细胞瘤眼球摘除术后病理与预后分析
引用本文:罗鑫,叶慧菁,丁运刚,杜毅,杨华胜.视网膜母细胞瘤眼球摘除术后病理与预后分析[J].眼科新进展,2014,0(12):1147-1151.
作者姓名:罗鑫  叶慧菁  丁运刚  杜毅  杨华胜
作者单位:510003 广东省广州市,中山大学中山眼科中心
摘    要:目的 分析视网膜母细胞瘤(retinoblastoma,Rb)侵犯眼球部位与患者预后之间的关系,为病情的预测和治疗提供依据。方法 回顾性分析2003年1月至2011年2月于中山大学中山眼科中心行眼球摘除术的单眼Rb患者。记录术后肿瘤侵犯的部位、治疗情况和生存情况并评估患者的5a生存率(5yearprobabilityevent-freesurvival,5-PEFS)。随访以患者死亡或至2012年2月截止,随访时间为(46.3±29.2)个月。结果 共有202例202眼患者纳入研究,其中筛板及筛板前侵犯所占比例最大(40.6%),5-PEFS也最高(96.1%);筛板后视神经侵犯和视神经断端侵犯者5-PEFS分别是82.5%和40.0%,三者比较差异有显著统计学意义(P<0.01)。筛板后视神经侵犯接受治疗的患者5-PEFS(91.6%)有高于未治疗者(66.7%)的趋势(P=0.09);视神经断端侵犯者接受治疗与未治疗的5-PEFS分别是50.0%和0(P<0.01),单纯脉络膜侵犯患者5-PEFS是93.8%,巩膜侵犯患者接受和未接受辅助化疗的5-PEFS分别是57.1% 和77.8%(P>0.05)。2例眼眶侵犯患者均死亡,4例患者眼球摘除术后眼眶复发,从眼球摘除术到眼眶复发的时间是5~15个月,平均为9.8个月。结论 Rb眼球摘除术后病理检查对患者预后的预测和辅助治疗有指导意义;眼球摘除术后2a,尤其1a内是Rb复发的高发期,这期间所有患者需要密切随诊。

关 键 词:视网膜母细胞瘤  化疗  病理  眼球摘除术

Analysis of histopathology and prognosis of retinoblastoma after enucleation
LUO Xin,YE Hui-Jing,DING Yun-Gang,DU Yi,YANG Hua-Sheng.Analysis of histopathology and prognosis of retinoblastoma after enucleation[J].Recent Advances in Ophthalmology,2014,0(12):1147-1151.
Authors:LUO Xin  YE Hui-Jing  DING Yun-Gang  DU Yi  YANG Hua-Sheng
Institution:Zhongshan Ophthalmic Center ,Sun Yat-Sen University , Guangzhou 510003 , Guangdong Province , China
Abstract:Objective To analyze the relationship between eyeball invasive locations and prognosis of retinoblastoma for metastasis after enucleation , and offer a reliable guide to adjuvant therapy. Methods Retrospective study was done about patients with unilateral retinoblastoma treated by enucleation without prior treatment at Zhongshan Ophthalmic Center of Sun Yat-Sen University between January 2003 and February 2011. The locations of tumor invasion , treatment and survival condition of patients were recorded,and the 5-PEFS ( 5 year probability event-free survival) was calculated. Follow-up visit ended until patients died or by February 2012. The follow-up period was (46. 3 + 29. 2 ) months. Results A total of 202 eyes of 202 patients were enrolled in this study. The patients with the laminar or prelaminar involvement accounted for the largest proportion ( 40. 6% ) . which had the highest 5-PEFS ( 96. 1% ) . The 5-PEFS of the patients with post-laminar optic nerve involvement and transection line of optic nerve involvement were 82. 5% and 40. 0% , respectively. The patients with post-laminar optic nerve involvement accepted adjuvant chemotherapy had a tendency of higher 5-PEFS (91. 6% ) than that of untreated patients ( 66. 7% ,P = 0. 09 ) . The 5-PEFS of patients accepted treatment with transection line of optic nerve involvement sigruficant higher than that of untreated patients (P < 0. 01 ) . The 5-PEFS of patients with isolated choroid invasion was 93. 8% . The 5-PEFS of patients with tumor invasion to sclera who received adjuvant chemotherapy and that of those did not receive adjuvant chemotherapy were respectively 77. 8% and 57. 1% ( P > 0. 05 ) . TAro patients with orbit invaded died. Four of 202 patients recurrented in orbit after enucleation. The average time from enucleation to relapse was 9. 8 months ( 5 - 15 months) . Conclrision Histopathology after enucleation may provide a reference to prognosis and adjuvant therapy. Almost all recurrences of retinoblastoma occur within 2 years , especially I year , after enucleation. during which all retinoblastoma patients have to keeping close follow-up.
Keywords:retinoblastoma  chemotherapy  pathology  enucleation
点击此处可从《眼科新进展》浏览原始摘要信息
点击此处可从《眼科新进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号